Ai-Designed Synthetic Proteins
Ai-Designed Synthetic Proteins : Recently, a landmark study published in Cell by researchers from Harvard University and collaborating institutions revealed a breakthrough in immunotherapy. The team successfully used AI-designed synthetic proteins to generate immune T cells at scale.
- About Ai-Designed Synthetic Proteins : Used to activate the Notch signalling pathway, essential for generating T cells.
o These proteins served as soluble synthetic agonists, replacing previous ineffective or inapplicable methods (like immobilised Notch ligands on culture dishes).
Helps in offering a major advance in immunotherapy and vaccine development.o Notch signalling, essential for cellular differentiation and immune response, previously lacked effective molecular activators suitable for human therapy.
o Using these synthetic agonists, the team successfully produced T cells at scale in laboratory bioreactors, addressing the demand in CAR-T cell therapies.
o The technology also shows promise in: Bridging T cells and cancer cells.
- Enhancing T cell-mediated killing.
- Neutralising immunosuppressive tumour microenvironments.
o This innovation opens doors to next-generation immunotherapies and cancer vaccines.
- About T-cells : A type of white blood cell involved in the immune system.
o There are two main types of T-cells: Helper T-cells: Coordinate and regulate the immune response.
- Killer T-cells: Destroy infected or abnormal cells directly.
o Functions : T-cells are essential for developing immunity against new pathogens.
- T-cells manage responses to recurring or chronic antigens.
Detailed Solutions & Explanations
